Literature DB >> 27637888

Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer.

Yi Zhong1, Anne Macgregor-Das2,3, Tyler Saunders2, Martin C Whittle4, Alvin Makohon-Moore1,2,3, Zachary A Kohutek5, Justin Poling2, Brian T Herbst1, Breanna M Javier1, Leslie Cope6, Steven D Leach1,7,8, Sunil R Hingorani4,9, Christine A Iacobuzio-Donahue10,8,11.   

Abstract

Purpose: TP53 and the TGFβ pathway are major mediators of pancreatic cancer metastasis. The mechanisms by which they cause hematogenous metastasis have not been fully explored.Experimental Design:KPC (LSL-KRASG12D/+;LSL-Trp53R172H/+; Ptf1aCre/+) mice were generated, and the frequency and morphology of organ-specific hematogenous metastases compared with that seen in KPTC and KTC littermates (Tgfbr2+/-). Key findings were validated in primary cells from each genotype and samples of human pancreatic cancer liver metastases.
Results: The frequency of hematogenous metastasis in KPTC mice was significantly lower than for KPC mice (41% vs. 68%, P < 0.05), largely due to a reduction in liver metastases. No differences were found between KPC and KPTC lung metastases, whereas liver metastases in KPTC mice showed a profound extravasation deficiency characterized by sinusoidal growth and lack of desmoplastic stroma. Analogous findings were confirmed in liver samples from patients indicating their clinical relevance. Portal vein colonization as a direct mode of access to the liver was observed in both mice and humans. Secretome analyses of KPC cells revealed an abundance of secreted prometastatic mediators including Col6A1 and Lcn2 that promoted early steps of metastatic colonization. These mediators were overexpressed in primary tumors but not metastases, suggesting that the ability to colonize is, in part, developed within the primary site, a phenomenon we refer to as the "Cinderella effect."Conclusions: These findings establish a novel paradigm for understanding pancreatic cancer metastasis and the observed clinical latencies of liver versus lung metastases specifically. Clin Cancer Res; 23(6); 1607-20. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27637888      PMCID: PMC5354987          DOI: 10.1158/1078-0432.CCR-15-1615

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  39 in total

1.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.

Authors:  Berna C Özdemir; Tsvetelina Pentcheva-Hoang; Julienne L Carstens; Xiaofeng Zheng; Chia-Chin Wu; Tyler R Simpson; Hanane Laklai; Hikaru Sugimoto; Christoph Kahlert; Sergey V Novitskiy; Ana De Jesus-Acosta; Padmanee Sharma; Pedram Heidari; Umar Mahmood; Lynda Chin; Harold L Moses; Valerie M Weaver; Anirban Maitra; James P Allison; Valerie S LeBleu; Raghu Kalluri
Journal:  Cancer Cell       Date:  2014-05-22       Impact factor: 31.743

2.  Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma.

Authors:  Andrew D Rhim; Paul E Oberstein; Dafydd H Thomas; Emily T Mirek; Carmine F Palermo; Stephen A Sastra; Erin N Dekleva; Tyler Saunders; Claudia P Becerra; Ian W Tattersall; C Benedikt Westphalen; Jan Kitajewski; Maite G Fernandez-Barrena; Martin E Fernandez-Zapico; Christine Iacobuzio-Donahue; Kenneth P Olive; Ben Z Stanger
Journal:  Cancer Cell       Date:  2014-05-22       Impact factor: 31.743

3.  Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades.

Authors:  Jordan M Winter; Murray F Brennan; Laura H Tang; Michael I D'Angelica; Ronald P Dematteo; Yuman Fong; David S Klimstra; William R Jarnagin; Peter J Allen
Journal:  Ann Surg Oncol       Date:  2011-07-15       Impact factor: 5.344

4.  Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy.

Authors:  Erlinda E Embuscado; Daniel Laheru; Francesca Ricci; Ki Jung Yun; Sten de Boom Witzel; Allison Seigel; Katie Flickinger; Manuel Hidalgo; G Steven Bova; Christine A Iacobuzio-Donahue
Journal:  Cancer Biol Ther       Date:  2005-05-12       Impact factor: 4.742

5.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

Authors:  Sunil R Hingorani; Lifu Wang; Asha S Multani; Chelsea Combs; Therese B Deramaudt; Ralph H Hruban; Anil K Rustgi; Sandy Chang; David A Tuveson
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

6.  Whole genomes redefine the mutational landscape of pancreatic cancer.

Authors:  Nicola Waddell; Marina Pajic; Ann-Marie Patch; David K Chang; Karin S Kassahn; Peter Bailey; Amber L Johns; David Miller; Katia Nones; Kelly Quek; Michael C J Quinn; Alan J Robertson; Muhammad Z H Fadlullah; Tim J C Bruxner; Angelika N Christ; Ivon Harliwong; Senel Idrisoglu; Suzanne Manning; Craig Nourse; Ehsan Nourbakhsh; Shivangi Wani; Peter J Wilson; Emma Markham; Nicole Cloonan; Matthew J Anderson; J Lynn Fink; Oliver Holmes; Stephen H Kazakoff; Conrad Leonard; Felicity Newell; Barsha Poudel; Sarah Song; Darrin Taylor; Nick Waddell; Scott Wood; Qinying Xu; Jianmin Wu; Mark Pinese; Mark J Cowley; Hong C Lee; Marc D Jones; Adnan M Nagrial; Jeremy Humphris; Lorraine A Chantrill; Venessa Chin; Angela M Steinmann; Amanda Mawson; Emily S Humphrey; Emily K Colvin; Angela Chou; Christopher J Scarlett; Andreia V Pinho; Marc Giry-Laterriere; Ilse Rooman; Jaswinder S Samra; James G Kench; Jessica A Pettitt; Neil D Merrett; Christopher Toon; Krishna Epari; Nam Q Nguyen; Andrew Barbour; Nikolajs Zeps; Nigel B Jamieson; Janet S Graham; Simone P Niclou; Rolf Bjerkvig; Robert Grützmann; Daniela Aust; Ralph H Hruban; Anirban Maitra; Christine A Iacobuzio-Donahue; Christopher L Wolfgang; Richard A Morgan; Rita T Lawlor; Vincenzo Corbo; Claudio Bassi; Massimo Falconi; Giuseppe Zamboni; Giampaolo Tortora; Margaret A Tempero; Anthony J Gill; James R Eshleman; Christian Pilarsky; Aldo Scarpa; Elizabeth A Musgrove; John V Pearson; Andrew V Biankin; Sean M Grimmond
Journal:  Nature       Date:  2015-02-26       Impact factor: 49.962

7.  Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.

Authors:  Nabeel Bardeesy; Andrew J Aguirre; Gerald C Chu; Kuang-Hung Cheng; Lyle V Lopez; Aram F Hezel; Bin Feng; Cameron Brennan; Ralph Weissleder; Umar Mahmood; Douglas Hanahan; Mark S Redston; Lynda Chin; Ronald A Depinho
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

8.  Overexpression of p53 protein in adenocarcinoma of the pancreas.

Authors:  J A DiGiuseppe; R H Hruban; S N Goodman; M Polak; F M van den Berg; D C Allison; J L Cameron; G J Offerhaus
Journal:  Am J Clin Pathol       Date:  1994-06       Impact factor: 2.493

9.  DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.

Authors:  Christine A Iacobuzio-Donahue; Baojin Fu; Shinichi Yachida; Mingde Luo; Hisashi Abe; Clark M Henderson; Felip Vilardell; Zheng Wang; Jesse W Keller; Priya Banerjee; Joseph M Herman; John L Cameron; Charles J Yeo; Marc K Halushka; James R Eshleman; Marian Raben; Alison P Klein; Ralph H Hruban; Manuel Hidalgo; Daniel Laheru
Journal:  J Clin Oncol       Date:  2009-03-09       Impact factor: 44.544

10.  Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas.

Authors:  Kamel Izeradjene; Chelsea Combs; Melissa Best; Aarthi Gopinathan; Amary Wagner; William M Grady; Chu-Xia Deng; Ralph H Hruban; N Volkan Adsay; David A Tuveson; Sunil R Hingorani
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

View more
  13 in total

Review 1.  Understanding Disease Biology and Informing the Management of Pancreas Cancer With Preclinical Model Systems.

Authors:  Martin C Whittle; Sunil R Hingorani
Journal:  Cancer J       Date:  2017 Nov/Dec       Impact factor: 3.360

2.  Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases.

Authors:  Matthew E Bechard; Anna E Word; Amanda V Tran; Xiaojing Liu; Jason W Locasale; Oliver G McDonald
Journal:  Oncogene       Date:  2018-05-30       Impact factor: 9.867

Review 3.  Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets.

Authors:  Martin C Whittle; Sunil R Hingorani
Journal:  Gastroenterology       Date:  2019-02-02       Impact factor: 22.682

Review 4.  Tumor microenvironment participates in metastasis of pancreatic cancer.

Authors:  Bo Ren; Ming Cui; Gang Yang; Huanyu Wang; Mengyu Feng; Lei You; Yupei Zhao
Journal:  Mol Cancer       Date:  2018-07-30       Impact factor: 27.401

5.  Unraveling the Molecular Tumor-Promoting Regulation of Cofilin-1 in Pancreatic Cancer.

Authors:  Silke D Werle; Julian D Schwab; Marina Tatura; Sandra Kirchhoff; Robin Szekely; Ramona Diels; Nensi Ikonomi; Bence Sipos; Jan Sperveslage; Thomas M Gress; Malte Buchholz; Hans A Kestler
Journal:  Cancers (Basel)       Date:  2021-02-10       Impact factor: 6.639

Review 6.  Pancreatic cancer stroma: an update on therapeutic targeting strategies.

Authors:  Abdel N Hosein; Rolf A Brekken; Anirban Maitra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-11       Impact factor: 73.082

7.  Pancreatic cancers suppress negative feedback of glucose transport to reprogram chromatin for metastasis.

Authors:  Matthew E Bechard; Rana Smalling; Akimasa Hayashi; Yi Zhong; Anna E Word; Sydney L Campbell; Amanda V Tran; Vivian L Weiss; Christine Iacobuzio-Donahue; Kathryn E Wellen; Oliver G McDonald
Journal:  Nat Commun       Date:  2020-08-13       Impact factor: 14.919

8.  Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma.

Authors:  Ziying Jian; Tao Cheng; Zhiheng Zhang; Susanne Raulefs; Kuangyu Shi; Katja Steiger; Nadja Maeritz; Karin Kleigrewe; Thomas Hofmann; Simone Benitz; Philipp Bruns; Daniel Lamp; Martin Jastroch; Jan Akkan; Carsten Jäger; Peilin Huang; Shuang Nie; Shanshan Shen; Xiaoping Zou; Güralp O Ceyhan; Christoph W Michalski; Helmut Friess; Jörg Kleeff; Bo Kong
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-07-26

9.  Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5.

Authors:  Eric D Young; Sharon J Manley; Thomas C Beadnell; Alexander E Shearin; Ken Sasaki; Rosalyn Zimmerman; Evan Kauffman; Carolyn J Vivian; Aishwarya Parasuram; Tomoo Iwakuma; Paul M Grandgenett; Michael A Hollingsworth; Maura O'Neil; Danny R Welch
Journal:  Br J Cancer       Date:  2020-10-07       Impact factor: 7.640

10.  SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization.

Authors:  Chao Dai; Jonathan P Rennhack; Taylor E Arnoff; Maneesha Thaker; Scott T Younger; John G Doench; August Yue Huang; Annan Yang; Andrew J Aguirre; Belinda Wang; Evan Mun; Joyce T O'Connell; Ying Huang; Katherine Labella; Jessica A Talamas; Ji Li; Nina Ilic; Justin Hwang; Andrew L Hong; Andrew O Giacomelli; Ole Gjoerup; David E Root; William C Hahn
Journal:  Cell Rep       Date:  2021-07-27       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.